This isnt specific to semaglutide , its consistent with the broader obesity medicine literature showing that pharmacotherapy, like lifestyle intervention, requires ongoing treatment for durable effect
Foods chosen are easy to digest and eaten in small portions to reduce discomfort
In a large cohort study from the United States involving more than 18,000 overweight or obese individuals, Rodriguez et al reported that the average weight loss after one year was 8.3% with semaglutide and 15.3% with tirzepatide
Villarreal OE, Xiao L, Allam J, Sorokin A, Yuan Y, Kopetz S , Raghav KP
With regular monitoring, individualized adjustments, and continued motivation, Troy Watson ensures that every step of the weight-loss journey feels guided, safe, and sustainable